Prosecution Insights
Last updated: November 15, 2026

New England Biolabs Inc.

Technology area: Biotechnology & Pharmaceuticals

11 pending office actions • 9 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Analysis

New England Biolabs Inc. has 11 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 11 distinct examiners across 9 distinct art units, reflecting broad prosecution coverage and multiple technical-unit assignments.

REGA, KYLE THOMAS is the busiest examiner, with 1 pending matter. No examiner concentration is shown, so portfolio management should emphasize centralized tracking of diverse office-action positions and careful coordination among the nine art units.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

11
Total Pending OAs
4
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
1
Due this week
3
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 7 days (1)Due ≤ 30 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (45%)
5
Medium (45%)
1
Easy (9%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (9%)
§103 only3 (27%)
§102 only1 (9%)
§112 only1 (9%)
Double-patenting + other1 (9%)
Multi-statute (no §101)4 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

11
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
REGA, KYLE THOMAS 1 62.8% +42.6%
RILEY, JEZIA 1 83.0% +7.2%
SALMON, KATHERINE D 1 42.7% +38.2%
PRIEST, AARON A 1 61.7% +25.4%
GIAMMONA, FRANCESCA FILIPPA 1 37.6% +59.9%
SHIN, DANA H 1 26.8% +26.9%
BUCHANAN, BAILEY CHEYENNE 1 40.0% +47.7%
HANDY, DWAYNE K 1 63.0% +24.9%
CASH, KAILEY ELIZABETH 1 28.6% +64.3%
LIPPOLIS, ALEXANDRA ROSE 1 48.7% +61.7%

Hard Cases (7)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 127d overdue
18323143 Double-Stranded DNA Deaminases and Uses Thereof BUCHANAN, BAILEY CHEYENNE 12d
18452104 Rapid Diagnostic Test for LAMP GIAMMONA, FRANCESCA FILIPPA 71d
18706431 Compositions and Methods for Detecting Pyrophosphate Products of Enzyme Reactions Using Pyridylazoaniline Dyes RILEY, JEZIA —
18562953 An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase SALMON, KATHERINE D —
18509884 Analysis of Chromatin Using a Nicking Enzyme PRIEST, AARON A —
18546896 Compositions and Methods for Labeling Modified Nucleotides in Nucleic Acids SHIN, DANA H —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 127d overdue
18969910 Programmable Cleavage of RNA REGA, KYLE THOMAS 30d overdue
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 6d
18323143 Double-Stranded DNA Deaminases and Uses Thereof BUCHANAN, BAILEY CHEYENNE 12d
17820372 Rolling Circle Reverse Transcription of Circular RNA LIPPOLIS, ALEXANDRA ROSE 22d
18452104 Rapid Diagnostic Test for LAMP GIAMMONA, FRANCESCA FILIPPA 71d
18562953 An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase SALMON, KATHERINE D —
18509884 Analysis of Chromatin Using a Nicking Enzyme PRIEST, AARON A —

Top Art Units

Art UnitApps
1681 2
1682 2
1636 1
1671 1
1635 1
1798 1
1683 1
1637 1
1684 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18969910 Programmable Cleavage of RNA REGA, KYLE THOMAS 1636 §103 Final Rejection 30d overdue Pending Dec 05, 2024
18706431 Compositions and Methods for Detecting Pyrophosphate Products of Enzyme Reactions Using Pyridylazoaniline Dyes RILEY, JEZIA 1681 §101§102§103Other Non-Final OA — Pending May 01, 2024
18562953 An Isothermal Diagnostic Test that Utilizes a Cas Protein and a Polymerase SALMON, KATHERINE D 1682 §102§103 Final Rejection — Pending Nov 21, 2023
18509884 Analysis of Chromatin Using a Nicking Enzyme PRIEST, AARON A 1681 §102§112 Non-Final OA — Pending Nov 15, 2023
18452104 Rapid Diagnostic Test for LAMP GIAMMONA, FRANCESCA FILIPPA 1671 §103§112 Final Rejection 71d Pending Aug 18, 2023
18546896 Compositions and Methods for Labeling Modified Nucleotides in Nucleic Acids SHIN, DANA H 1635 §112 Non-Final OA — Pending Aug 17, 2023
18323143 Double-Stranded DNA Deaminases and Uses Thereof BUCHANAN, BAILEY CHEYENNE 1682 §103§112 Final Rejection 12d Pending May 24, 2023
18155975 Isolation of High Molecular Weight DNA Using Beads HANDY, DWAYNE K 1798 §103 Non-Final OA 6d Pending Jan 18, 2023
17907482 Compositions and Methods for Detecting Molecular Targets on Chromosomal DNA CASH, KAILEY ELIZABETH 1683 §103DP Final Rejection 127d overdue Pending Sep 27, 2022
17820372 Rolling Circle Reverse Transcription of Circular RNA LIPPOLIS, ALEXANDRA ROSE 1637 §103 Final Rejection 22d Pending Aug 17, 2022
17825346 Method for Removing and/or Detecting Nucleic Acids Having Mismatched Nucleotides ZHANG, KAIJIANG 1684 §102Other Final Rejection 13d Pending May 26, 2022

Managing New England Biolabs Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does New England Biolabs Inc. have?

New England Biolabs Inc. has 11 pending office actions as of November 2026, spread across 9 art units and 11 examiners.

Which USPTO examiner handles the most New England Biolabs Inc. applications?

Kyle Thomas Rega has the most, with 1 of New England Biolabs Inc.'s pending office actions.

What technology area are New England Biolabs Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month